Jean-Michel Foidart
Founder chez MITHRA PHARMACEUTICALS S.A.
Profil
Jean-Michel Foidart is the founder of Mithra Pharmaceuticals SA, which was founded in 1999.
He is also the founder of Uteron Pharma SA and EyeD Pharma SA. Dr. Foidart's current job positions include being a Director at Belma Technologies SA since 2015, a Director at EXO Biologics SA since 2019, and a Director at Dendrogenix SA. His former job positions include being a Director at ImCyse SA and Head-Gynecology & Obstetrics at the University of Liege.
Dr. Foidart obtained a doctorate degree from the University of Liege.
Postes actifs de Jean-Michel Foidart
| Sociétés | Poste | Début |
|---|---|---|
| MITHRA PHARMACEUTICALS S.A. | Founder | 08/07/1999 |
EXO Biologics SA
 EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | Director/Board Member | 29/08/2019 |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | Director/Board Member | - |
Belma Technologies SA
 Belma Technologies SA Miscellaneous Commercial ServicesCommercial Services Belma Technologies SA is a Belgian company that specializes in biotechnological research and development. The company is based in Liege, Belgium. Belma Technologies was founded in 2015 by Brigitte Evrard, Maria Alvarez Gonzalez. | Director/Board Member | 29/10/2015 |
Anciens postes connus de Jean-Michel Foidart
| Sociétés | Poste | Fin |
|---|---|---|
EyeD Pharma SA
 EyeD Pharma SA Medical SpecialtiesHealth Technology EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium. | Founder | - |
Uteron Pharma SA
 Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Founder | - |
| University of Liege | Corporate Officer/Principal | - |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Director/Board Member | - |
Formation de Jean-Michel Foidart
| University of Liege | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MITHRA PHARMACEUTICALS S.A. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Electronic Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Health Technology |
Belma Technologies SA
Belma Technologies SA Miscellaneous Commercial ServicesCommercial Services Belma Technologies SA is a Belgian company that specializes in biotechnological research and development. The company is based in Liege, Belgium. Belma Technologies was founded in 2015 by Brigitte Evrard, Maria Alvarez Gonzalez. | Commercial Services |
EyeD Pharma SA
EyeD Pharma SA Medical SpecialtiesHealth Technology EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium. | Health Technology |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | Health Technology |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | Health Technology |
